Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.3100 (-1.1%) ($6.3000 - $6.3100) on Wed. Aug. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.11% (three month average) | RSI | 38 | Latest Price | $6.3100(-1.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2% a day on average for past five trading days. | Weekly Trend | IOVA declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) SMH(49%) IPO(38%) SLV(35%) IGOV(32%) GDXJ(31%) | Factors Impacting IOVA price | IOVA will decline at least -2.555% in a week (0% probabilities). UUP(-37%) TAN(-35%) XME(-29%) XLU(-27%) TBT(-25%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.555% (StdDev 5.11%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.81(-176.23%) | Resistance Level | $6.94 | 5 Day Moving Average | $6.26(0.8%) | 10 Day Moving Average | $6.69(-5.68%) | 20 Day Moving Average | $6.94(-9.08%) | To recent high | -30.7% | To recent low | 3.9% | Market Cap | $924m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |